---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-197192"
form_type: "8-K"
ticker: "RMD"
cik: "0000943819"
company_name: "RESMED INC"
filed_at: "2026-04-30T23:59:59+00:00"
generated_at: "2026-05-15T01:34:47.439092+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ResMed Q3 revenue $1.43B (+11%); GAAP EPS $2.74, dividend $0.60

## Summary
- Revenue $1,431.4M (+11% reported, +8% constant currency).
- GAAP diluted EPS $2.74 (+10% YoY); non-GAAP diluted EPS $2.86 (+21% YoY).
- GAAP gross margin 62.2% (+290 bps); non-GAAP gross margin 62.8% (+290 bps).
- Quarterly dividend $0.60/share declared; record 5/14/2026, payable 6/18/2026.
- Operating cash flow $554M; $262M returned via buybacks and dividends in Q3.

## SEC filing metadata
- accession: 0001193125-26-197192
- form_type: 8-K
- ticker: RMD
- cik: 0000943819
- company_name: RESMED INC
- filed_at: 2026-04-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/943819/000119312526197192/0001193125-26-197192-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/943819/000119312526197192/d146862d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-197192
- JSON: https://secwatch.observer/filing/0001193125-26-197192.json
- Plain text: https://secwatch.observer/filing/0001193125-26-197192.txt

## Key facts
- Earnings Releases
  RESMED INC reported the quarter ended March 31, 2026 results: revenue $1,431.4, net income $398.7, EPS $2.74.
  - Period: the quarter ended March 31, 2026
  - Revenue: $1,431.4
  - Net income: $398.7
  - EPS: $2.74
  - Result: reported results
  source text: Results and Operating Metrics Unaudited; $ in millions, except for per share amounts Three Months Ended March 31, 2026 March 31, 2025 % Change Constant Currency (A) Revenue $ 1,431.4 $ 1,291.7 11 % 8 % Gross margin 62.2 % 59.3 % 5 Non-GAAP gross margin (B) 62.8 % 59.9 % 5 Selling, general, and administrative expenses 285.7 245.3 16 11 Non-GAAP selling,
  evidence_url: https://www.sec.gov/Archives/edgar/data/943819/000119312526197192/0001193125-26-197192-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.